Immuron Limited (IMRN) Income Statement

NASDAQ: IMRNRevenue, profits, margins and EPS over 1 years.

IMRN FY2026 at a glance

Fiscal year ended June 30, 2026 · U.S. dollars
Revenue
$7.5M
FY2026 · hover or tap a bar for each year
FY2026: $7.5M
FY2026FY2026
Gross profit
$4.9M
FY2026 · hover or tap a bar for each year
FY2026: $4.9M
FY2026FY2026
Operating income
−$4.6M
FY2026 · hover or tap a bar for each year
FY2026: −$4.6M
FY2026FY2026
Net income
−$3.8M
FY2026 · hover or tap a bar for each year
FY2026: −$3.8M
FY2026FY2026
EPS (diluted)
−$0.46
FY2026 · hover or tap a bar for each year
FY2026: −$0.46
FY2026FY2026
Net profit margin
−49.8%
FY2026 · hover or tap a point for each year
FY2026FY2026

IMRN revenue and net income

RevenueNet incomeNet margin (right axis)

Where IMRN's revenue goes

FY2026
Revenue
$7.5M100.0%
Cost of revenue
−$2.7M−35.5%
Gross profit
$4.9M64.5%
Other operating expenses
−$9.5M−125.9%
Operating income
−$4.6M−61.4%
Interest & other income
$267,1973.5%
Income taxes
$609,9858.1%
Net income
−$3.8M−49.8%

Each bar shows an amount and its share of revenue. IMRN kept −49.8% of revenue as net income.

IMRN profit margins

GrossOperatingNet

IMRN growth rates

to FY2026
1 year3 years5 years10 years
Revenue————
Gross profit————
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

IMRN quarterly EPS vs estimates

Reported EPSAnalyst estimate

Immuron beat the analyst EPS estimate in 6 of the last 8 quarters.

IMRN income statement

Immuron Limited annual income statement
FY2026
Revenue$7.5M
Cost of revenue$2.7M
Gross profit$4.9M
Total operating expenses$9.5M
Operating income−$4.6M
Interest expense$14,390
Income before taxes−$4.4M
Income taxes−$609,985
Net income−$3.8M
EBITDA−$4.6M
EPS (diluted)−$0.46
Gross margin64.5%
Operating margin−61.4%
Net margin−49.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in IMRN's financial statements (latest annual report filed September 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

IMRN financial results

In fiscal year 2026 (ended June 30, 2026), Immuron reported revenue of $7.5 million. It had a net loss of $3.8 million, a net profit margin of −49.8%. Diluted earnings per share came to −$0.46.

See the IMRN stock overview for the latest quote and news, or the IMRN chart for price history and technical indicators.

IMRN income statement FAQ

What is Immuron's annual revenue?

Immuron reported total revenue of $7.5 million for fiscal year 2026, which ended on June 30, 2026.

Is Immuron profitable?

No. Immuron reported a net loss of $3.8 million in fiscal 2026, a net profit margin of −49.8%; its operating margin was −61.4%.

What is Immuron's gross margin?

Immuron's gross margin was 64.5% in fiscal 2026: for every $100 of revenue, Immuron kept $64 after the direct cost of its products and services.

What are Immuron's earnings per share?

Immuron earned $-0.46 per diluted share in fiscal 2026.

When does Immuron's fiscal year end?

Immuron's fiscal year ends in June. The latest annual report covers the year ended June 30, 2026 and was filed on September 24, 2026.

Biotechnology income statements